Pleiotropic renal actions of erythropoietin

Lancet

Volumn 365, Issue 9474, 2005, Pages 1890-1892

  Chatterjee, Prabal K ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASIALOERYTHROPOIETIN; ERYTHROPOIETIN; NEUROPROTECTIVE AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANEMIA; BLOOD PRESSURE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEMATOCRIT; HEMATOPOIESIS; HUMAN; HYPOXIA; ISCHEMIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; NEPHROTOXICITY; NERVOUS SYSTEM INJURY; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SURVIVAL; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 19744371361     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66622-6     Document Type: Short Survey

References (31)

1. ML Brines, P Ghezzi, S Keenan Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci USA 97 2000 10526 31
2. M Abdelrahman, EJ Sharples, MC McDonald Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia Shock 22 2004 63 69
3. AK Junk, A Mammis, SI Savitz Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury Proc Natl Acad Sci USA 99 2002 10659 64
4. M Celik, N Gokmen, S Erbayraktar Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc Natl Acad Sci USA 99 2002 2258 63
5. F Squadrito, D Altavilla, G Squadrito Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock Br J Pharmacol 127 1999 482 88
6. C Heeschen, A Aicher, R Lehmann Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization Blood 102 2003 1340 46
7. M Buemi, M Galeano, A Sturiale Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds Shock 22 2004 169 73
8. FH Bahlmann, R Song, SM Boehm Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure Circulation 110 2004 1006 12
9. T Nemoto, N Yokota, WF Keane, H Rabb Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure Kidney Int 59 2001 246 51
10. NSA Patel, EJ Sharples, S Cuzzocrea Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo Kidney Int 66 2004 983 89
11. H Gong, W Wang, T-H Kwon EPO and α-MSH prevent ischemia/ reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney Kidney Int 66 2004 683 95
12. DA Vesey, C Cheung, B Pat, Z Endre, G Gobé, DW Johnson Erythropoietin protects against ischaemic acute renal injury Nephrol Dial Transplant 19 2004 348 55
13. EJ Sharples, N Patel, P Brown Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion J Am Soc Nephrol 15 2004 2115 24
14. CW Yang, C Li, JY Jung Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney FASEB J 17 2003 1754 55
15. C Bagnis, H Beaufils, C Jacquiaud Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat Nephrol Dial Transplant 16 2001 932 38
16. C Westenfelder, DL Biddle, RL Baranowski Human, rat, and mouse kidney cells express functional erythropoietin receptors Kidney Int 55 1999 808 20
17. M Tapolyai, S Kadomatsu, M Perera-Chong r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline BMC Nephrol 4 2003 3
18. JC Fink, SA Blahut, M Reddy, PD Light Use of erythropoietin before the initiation of dialysis and its impact on mortality Am J Kidney Dis 37 2001 348 55
19. A Besarab, WK Bolton, JK Browne The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 1998 584 90
20. DL Garcia, S Anderson, HG Rennke, BM Brenner Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass Proc Natl Acad Sci USA 85 1988 6142 46
21. CG Schnackenberg Oxygen radicals in cardiovascular-renal disease Curr Opin Pharmacol 2 2002 121 25
22. E Pillebout, M Burtin, HT Yuan Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions Am J Pathol 159 2001 547 60
23. H Ehrenreich, M Hasselblatt, C Dembowski Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 2002 495 505
24. DJ Shaskey, GA Green Sports haematology Sports Med 29 2000 27 38
25. T Slowinski, N Schulz, FT Ruschitzka Pattern of prepro-endothelin-1 expression revealed by reporter-gene activity in kidneys of erythropoietin- overexpressing mice Clin Sci 103 2002 44S 47S
26. G Acs, P Acs, SM Beckwith Erythropoietin and erythropoietin receptor expression in human cancer Cancer Res 61 2001 3561 65
27. B Leyland-Jones Breast cancer trial with erythropoietin terminated unexpectedly Lancet Oncol 4 2003 459 60
28. A Österborg New erythropoietic proteins: rationale and clinical data Semin Oncol 31 2004 12 18
29. M Leist, P Ghezzi, G Grasso Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239 42
30. S Erbayraktar, G Grasso, A Sfacteria Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo Proc Natl Acad Sci USA 100 2003 6741 46
31. X Wang, C Zhu, X Wnag The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin J Neurochem 91 2004 900 10